URochester Medicine / Labs / Burack Lab / Publications

Recent Publications

1. Vodička P
2. El-Galaly TC
3. Prochazka V
4. Flowers CR
5. Villa D
6. Dietrich CE
7. Jakobsen LH
8. Ghesquieres H
9. Clausen MR
10. Kridel R
11. Cheah CY
12. Hawkes EA
13. Wahlin BE
14. Gandhi MK
15. Larson MC
16. Cahn EJ
17. Friedberg JW
18. Martin P
19. Chihara D
20. Cohen JB
21. Habermann TM
22. Casulo C
23. Wang Y
24. Brown PN
25. Mou E
26. Belada D
27. Janikova A
28. Mocikova H
29. Burack R
30. Lossos IS
31. Kahl BS
32. Smedby KE
33. Sehn LH
34. Trněný M
35. Cerhan JR
36. Maurer MJ
Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy.; Blood. 2026 Apr 14.
1. O'Malley DP
2. Cherry DA
3. Burack WR
More Than Skin Deep: Histopathologic Assessment of Tattoo Ink Deposition in Lymph Nodes.; International journal of surgical pathology. 2026 Mar 31.
1. Yeo YY
2. Qiu H
3. Bai Y
4. Zhu B
5. Chang Y
6. Iannelli F
7. Yiu SPT
8. Yeung J
9. Michel HA
10. Wang Y
11. Wang Y
12. Wu W
13. Wright K
14. Shaban M
15. Sadigh S
16. Nkosi D
17. Shanmugam V
18. Rock P
19. Cramer P
20. Paczkowska J
21. Stephan P
22. Liao G
23. Huang AY
24. Wang H
25. Chen H
26. Frauenfeld L
27. Kaufmann L
28. Pileri S
29. Mitra B
30. Gewurz BE
31. Zhao B
32. Nolan GP
33. Zhang B
34. Shalek AK
35. Angelo M
36. Schürch CM
37. Mahmood F
38. Chiarle R
39. Ma Q
40. Burack WR
41. Shipp MA
42. Rodig SJ
43. Jiang S
Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironment.; Cell reports. Medicine. 2026 Mar 31.
1. Yiu SPT
2. Chang Y
3. Yeo YY
4. Qiu H
5. Wu W
6. Michel HA
7. Jin X
8. Huang R
9. Kure S
10. Parmelee L
11. Luo S
12. Cramer P
13. Lee JL
14. Wang Y
15. Zhao Z
16. Yeung J
17. El Ahmar N
18. Simsek B
19. Mohanna R
20. Van Orden M
21. Lu WS
22. Livak KJ
23. Li S
24. Gao C
25. Burgess M
26. Keane C
27. Shahryari J
28. Kingsley LG
29. Al-Humadi RN
30. Nasr S
31. Nkosi D
32. Sadigh S
33. Rock P
34. Frauenfeld L
35. Kaufmann L
36. Zhu B
37. Basak A
38. Dhanikonda N
39. Chan CN
40. Krull J
41. Cho YW
42. Chen CY
43. Brown J
44. Wang H
45. Zhao B
46. Lee JJ
47. Loo LH
48. Kim DM
49. Boussiotis VA
50. Zhang B
51. Wei K
52. Shalek AK
53. Howitt BE
54. Signoretti S
55. Schürch CM
56. Hodi FS
57. Burack WR
58. Rodig SJ
59. Ma Q
60. Jiang S
Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.; Cancer discovery. 2026 Mar 24.
1. El Hussein S
2. George GV
3. Adlowitz DG
4. Benedict LB
5. Jelloul FZ
6. Medeiros LJ
7. Burack WR
8. O'Malley DP
STAT6 mutational status and expression in primary mediastinal large B-cell lymphoma.; Pathology. 2026 Mar 17.
1. Chiodin G
2. Tatterton DJ
3. Rock PJ
4. Del Rio L
5. Snook E
6. James S
7. Duriez PJ
8. Di Re M
9. Verdoes M
10. Lanham S
11. Hodson DJ
12. Burack R
13. Forconi F
DC-SIGN Binding to the Surface Ig Oligomannose-type Glycans Promotes Follicular Lymphoma Cell Adhesion and Survival.; Blood. 2026 Jan 20.
1. Maurer MJ
2. Prochazka VK
3. El-Galaly TC
4. Flowers CR
5. Villa D
6. Bachy E
7. Cahn EJ
8. Fournier M
9. Larson MC
10. Dietrich CE
11. Jakobsen LH
12. Ghesquières H
13. Kridel R
14. Gandhi MK
15. Cheah CY
16. Hawkes EA
17. Seymour JF
18. Freeman CL
19. Clausen MR
20. Wahlin BE
21. Friedberg JW
22. Casulo C
23. Habermann TM
24. Wang Y
25. Nastoupil LJ
26. de Nully Brown P
27. Belada D
28. Janíková A
29. Mocikova H
30. Fürst T
31. Feugier P
32. Tilly H
33. Haioun C
34. Davies AJ
35. Cartron G
36. Burack R
37. Chihara D
38. Martin P
39. Cohen JB
40. Lossos IS
41. Kahl BS
42. Sehn LH
43. Smedby KE
44. Salles G
45. Trneny M
46. Link BK
47. Morschhauser F
48. Cerhan JR
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025 Dec 02.
1. Mondello P
2. Negaard B
3. Feldman AL
4. Link BK
5. Casulo C
6. Chihara D
7. Russler-Germain D
8. Romancik J
9. Gribbin C
10. Haddadi S
11. Mou E
12. Micallef IN
13. Johnston PB
14. Novak J
15. Wang Y
16. King RL
17. Novak AJ
18. Habermann TM
19. Martin P
20. Kahl B
21. Nowakowski GS
22. Nastoupil LJ
23. Cerhan JR
24. Flowers CR
25. Lossos IS
26. Burack RW
27. Maurer MJ
28. Ansell SM
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts.; Blood cancer journal; Vol 15(1), pp. 134. 2025 Aug 08.
1. Superdock MA
2. Rimsza LM
3. Wallace DS
4. Strawderman M
5. Ramsower CA
6. Steiner RE
7. Faugh T
8. Maurer MJ
9. Link BK
10. Rosenthal AC
11. Burack WR
12. Syrbu SI
13. Feldman AL
14. Rock PJ
15. Robetorye RS
16. Cerhan JR
17. Flowers CR
18. Friedberg JW
19. Casulo C
Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study.; Leukemia & lymphoma. 2025 Aug 06.
1. Burack WR
2. Lichtman MA
The Complete Blood Count-Time to Assess What Is Impactful and What Is Distracting.; JAMA network open; Vol 8(6), pp. e2514055. 2025 Jun 02.
1. Sharma S
2. Rodems BJ
3. Baker CD
4. Kaszuba CM
5. Franco EI
6. Smith BR
7. Ito T
8. Swovick K
9. Welle K
10. Zhang Y
11. Rock P
12. Chaves FA
13. Ghaemmaghami S
14. Calvi LM
15. Ganguly A
16. Burack WR
17. Becker MW
18. Liesveld JL
19. Brookes PS
20. Munger JC
21. Jordan CT
22. Ashton JM
23. Bajaj J
Taurine from tumour niche drives glycolysis to promote leukaemogenesis.; Nature. 2025 May 14.
1. George GV
2. Kajstura M
3. Jajosky AN
4. Fang H
5. Jelloul FZ
6. Evans AG
7. Burack WR
8. Bennett JM
9. Medeiros LJ
10. Wang W
11. El Hussein S
Association Between B-Cell Marker Expression and RUNX1 Lesions in Acute Myeloid Leukemia, Beyond RUNX1::RUNX1T1 Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia-B/Myeloid.; Cancers; Vol 17(8). 2025 Apr 18.
1. Yeo YY
2. Chang Y
3. Qiu H
4. Yiu SPT
5. Michel HA
6. Wu W
7. Jin X
8. Kure S
9. Parmelee L
10. Luo S
11. Cramer P
12. Lee JL
13. Wang Y
14. Yeung J
15. Ahmar NE
16. Simsek B
17. Mohanna R
18. Orden MV
19. Lu W
20. Livak KJ
21. Li S
22. Shahryari J
23. Kingsley L
24. Al-Humadi RN
25. Nasr S
26. Nkosi D
27. Sadigh S
28. Rock P
29. Frauenfeld L
30. Kaufmann L
31. Zhu B
32. Basak A
33. Dhanikonda N
34. Chan CN
35. Krull J
36. Cho YW
37. Chen CY
38. Lee JYJ
39. Wang H
40. Zhao B
41. Loo LH
42. Kim DM
43. Schurch CM
44. Shalek AK
45. Boussiotis V
46. Zhang B
47. Howitt B
48. Signoretti S
49. Hodi FS
50. Burack WR
51. Rodig SJ
52. Ma Q
53. Jiang S
Same-Slide Spatial Multi-Omics Integration Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.; bioRxiv : the preprint server for biology. 2024 Dec 22.
1. Day JR
2. Larson MC
3. Durani U
4. Koff JL
5. Wang Y
6. Habermann TM
7. Lossos IS
8. Nastoupil LJ
9. Strouse CS
10. Chihara D
11. Martin P
12. Leonard JP
13. Cohen JB
14. Kahl BS
15. Ruan J
16. Burack R
17. Friedberg JW
18. Cerhan JR
19. Flowers CR
20. Link BL
21. Maurer MJ
22. Casulo C
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium.; Blood advances. 2024 Nov 27.
1. Abro B
2. Maurer MJ
3. Habermann TM
4. Burack R
5. Chapman JR
6. Cohen JB
7. Friedberg JW
8. Inghirami GG
9. Kahl BS
10. Larson MC
11. Link BL
12. Lossos IS
13. Martin P
14. McDonnell T
15. Nastoupil LJ
16. Riska S
17. Syrbu SI
18. Vega F
19. Vij K
20. Flowers CR
21. Cerhan JR
22. Jaye DL
23. Feldman AL
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO Cohort Study analysis.; Blood. 2024 Sep 10.
1. George GV
2. Aldowitz DG
3. Jajosky AN
4. Wallace DS
5. Burack WR
6. Friedberg JW
7. El Hussein S
Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?; EJHaem; Vol 5(3), pp. 599-602. 2024 Apr 24.
1. Yeo YY
2. Qiu H
3. Bai Y
4. Zhu B
5. Chang Y
6. Yeung J
7. Michel HA
8. Wright K
9. Shaban M
10. Sadigh S
11. Nkosi D
12. Shanmugam V
13. Rock P
14. Tung Yiu SP
15. Cramer P
16. Paczkowska J
17. Stephan P
18. Liao G
19. Huang AY
20. Wang H
21. Chen H
22. Frauenfeld L
23. Mitra B
24. Gewurz BE
25. Schürch CM
26. Zhao B
27. Nolan GP
28. Zhang B
29. Shalek AK
30. Angelo M
31. Mahmood F
32. Ma Q
33. Burack WR
34. Shipp MA
35. Rodig SJ
36. Jiang S
Epstein-Barr Virus Orchestrates Spatial Reorganization and Immunomodulation within the Classic Hodgkin Lymphoma Tumor Microenvironment.; bioRxiv : the preprint server for biology. 2024 Mar 07.
1. Zhou T
2. Curry CV
3. Khanlari M
4. Shi M
5. Cui W
6. Peker D
7. Chen W
8. Wang E
9. Gao J
10. Shen Q
11. Xie W
12. Jelloul FZ
13. King RL
14. Yuan J
15. Wang X
16. Zhao C
17. Obiorah IE
18. Courville EL
19. Nomura E
20. Cherian S
21. Xu ML
22. Burack WR
23. Liu HX
24. Jabbour EJ
25. Takahashi K
26. Wang W
27. Wang SA
28. Khoury JD
29. Medeiros LJ
30. Hu S
Genetics and pathologic landscape of lineage switch of acute leukemia during therapy.; Blood cancer journal; Vol 14(1), pp. 19. 2024 Jan 25.
1. Cerhan JR
2. Maurer MJ
3. Link BK
4. Feldman AL
5. Habermann TM
6. Jaye DL
7. Burack WR
8. McDonnell TJ
9. Vega F
10. Chapman JR
11. Syrbu S
12. Vij KR
13. Inghirami G
14. Leonard JP
15. Bernal-Mizrachi L
16. Farooq U
17. Witzig TE
18. Weiner GJ
19. Wang Y
20. Alderuccio JP
21. Slager SL
22. Larson MC
23. Riska SM
24. Gysbers BJ
25. Lunde JJ
26. Reicks TW
27. Ayers AA
28. O'Leary CB
29. Yost KJ
30. Liu H
31. Nowakowski GS
32. Ruan J
33. Chihara D
34. Koff JL
35. Casulo C
36. Thompson CA
37. Cohen JB
38. Kahl BS
39. Nastoupil LJ
40. Lossos IS
41. Friedberg JW
42. Martin P
43. Flowers CR
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.; American journal of hematology. 2024 Jan 13.
1. Burack WR
2. Lichtman MA
The Complete Blood Count: Increasing Its Precision and Impact.; Annals of internal medicine; Vol 176(8), pp. eL230165. 2023 Aug.
1. Burack WR
2. Li H
3. Adlowitz DG
4. Spence JM
5. Rimsza LM
6. Shadman M
7. Spier C
8. Kaminski MS
9. Leonard JP
10. Leblanc M
11. Smith SM
12. Friedberg JW
Subclonal TP53 mutation are frequent and predict resistance to radio-immunotherapy in follicular lymphoma.; Blood advances. 2023 Jun 28.
1. Centor RM
2. Burack WR
3. Lichtman MA
Annals On Call - The Complete Blood Count: Cleaning Up the Clutter.; Annals of internal medicine. 2023 Apr 04.
1. Archibald WJ
2. Baran AM
3. Williams AM
4. Salloum RM
5. Richard Burack W
6. Evans AG
7. Syposs CR
8. Zent CS
The role of splenectomy in management of splenic B-cell lymphomas.; Leukemia research; Vol 128, pp. 107053. 2023 Mar 02.
1. George GV
2. Wallace DS
3. Wang Y
4. Carney J
5. Elsadawi M
6. Burack WR
7. Evans AG
8. Barr PM
9. Velez MJ
10. El Hussein S
ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.; Histopathology. 2023 Jan 30.
1. Maurer MJ
2. Casulo C
3. Larson MC
4. Habermann TM
5. Lossos IS
6. Wang Y
7. Nastoupil LJ
8. Strouse C
9. Chihara D
10. Martin P
11. Cohen JB
12. Kahl BS
13. Burack WR
14. Koff JL
15. Mun Y
16. Masaquel A
17. Wu M
18. Wei MC
19. Shewade A
20. Li J
21. Cerhan JR
22. Link BK
23. Flowers CR
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.; Haematologica. 2023 Jan 30.
1. El Hussein S
2. Fang H
3. Jelloul FZ
4. Wang W
5. Loghavi S
6. Miranda RN
7. Friedberg JW
8. Burack WR
9. Evans AG
10. Xu J
11. Medeiros LJ
T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic Features.; Archives of pathology & laboratory medicine. 2023 Jan 07.
1. El Hussein S
2. Yabe M
3. Wang W
4. Pemmaraju N
5. Loghavi S
6. Jelloul FZ
7. Fang H
8. Medeiros LJ
9. Burack WR
10. Evans AG
11. Liesveld JL
12. Bennett JM
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms.; EJHaem; Vol 3(3), pp. 954-957. 2022 Jul 03.
1. El Hussein S
2. Wang X
3. Fang H
4. Jelloul FZ
5. Wang W
6. Loghavi S
7. Vega F
8. Miranda RN
9. Muzzafar T
10. Manning JT
11. Khoury JD
12. Burack WR
13. Evans AG
14. Medeiros LJ
Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D.; The American journal of surgical pathology. 2022 May 16.
1. Casulo C
2. Larson MC
3. Lunde JJ
4. Habermann TM
5. Lossos IS
6. Wang Y
7. Nastoupil LJ
8. Strouse C
9. Chihara D
10. Martin P
11. Cohen JB
12. Kahl BS
13. Burack WR
14. Koff JL
15. Mun Y
16. Masaquel A
17. Wu M
18. Wei MC
19. Shewade A
20. Li J
21. Cerhan J
22. Flowers CR
23. Link BK
24. Maurer MJ
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.; The Lancet. Haematology; Vol 9(4). 2022 Apr.
1. Liu L
2. Adlowitz DG
3. Rock P
4. Casulo C
5. Burack WR
Hypergammaglobulinemia as a presenting feature of Mantle cell lymphoma.; Leukemia & lymphoma. 2022 Mar 31.
1. Komisarof J
2. Lipof J
3. DiTursi J
4. Chowdhry A
5. Grace Choung HY
6. Burack WR
7. Constine L
8. Passero F
An Unusual Case of Multiple Myeloma with Light-Chain Cast Nephropathy Secondary to a Very Large Plasmacytoma without Bone Marrow Involvement.; Case reports in hematology; Vol 2022. 2022.
1. Zengin HB
2. Reyes-Barron C
3. Cusick E
4. Cordisco M
5. Katzman PJ
6. Burack WR
7. Scott G
A Young Boy With Hemophagocytic Lymphohistiocytosis Presenting With Vaccine-Related Granulomatous Dermatitis: A Case Report and Literature Review.; The American Journal of dermatopathology; Vol 43(12). 2021 Dec 01.
1. Chiodin G
2. Allen JD
3. Bryant D
4. Rock P
5. Martino EA
6. Valle-Argos B
7. Duriez PJ
8. Watanabe Y
9. Henderson I
10. Blachly JS
11. McCann KJ
12. Strefford JC
13. Packham G
14. Geijtenbeek TB
15. Figdor C
16. Wright G
17. Staudt LM
18. Burack R
19. Bowden T
20. Crispin M
21. Stevenson FK
22. Forconi F
Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.; Blood. 2021 Aug 23.
1. Valle-Argos B
2. Chiodin G
3. Bryant DJ
4. Taylor J
5. Lemm E
6. Duriez PJ
7. Rock PJ
8. Strefford JC
9. Forconi F
10. Burack RW
11. Packham G
12. Stevenson FK
DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity.; Scientific reports; Vol 11(1). 2021 Jun 03.
1. Palacios F
2. Yan XJ
3. Ferrer G
4. Chen SS
5. Vergani S
6. Yang X
7. Gardner J
8. Barrientos JC
9. Rock P
10. Burack R
11. Kolitz JE
12. Allen SL
13. Kharas MG
14. Abdel-Wahab O
15. Rai KR
16. Chiorazzi N
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.; Leukemia; Vol 35(4). 2021 Apr.
1. Fries C
2. Adlowitz DG
3. Spence JM
4. Spence JP
5. Rock PJ
6. Burack WR
Acute lymphoblastic leukemia clonal distribution between bone marrow and peripheral blood.; Pediatric blood & cancer. 2020 Apr 11.
1. Meacham PJ
2. Williams AM
3. Strawderman M
4. Baran AM
5. Archibald WJ
6. Wallace DS
7. Tschernia NP
8. Burack WR
9. Barr PM
10. Zent CS
Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).; Leukemia & lymphoma. 2020 Mar 16.
1. Norris PAA
2. Segel GB
3. Burack WR
4. Sachs UJ
5. Lissenberg-Thunnissen SN
6. Vidarsson G
7. Bayat B
8. Cserti-Gazdewich CM
9. Callum J
10. Lin Y
11. Branch D
12. Kapur R
13. Semple JW
14. Lazarus AH
FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia.; Haematologica. 2020 Feb 27.
1. Hudson CA
2. Burack WR
3. Bennett JM
Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemia.; Leukemia research; Vol 73. 2018 Aug 28.
1. Hudson CA
2. Burack WR
3. Leary PC
4. Bennett JM
Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic Leukemia.; American journal of clinical pathology. 2018 Jul 05.
1. Aslam R
2. Burack WR
3. Segel GB
4. McVey M
5. Spence SA
6. Semple JW
Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells.; British journal of haematology; Vol 181(2). 2018 Apr.
1. Barr PM
2. Li H
3. Burack WR
4. LeBlanc M
5. Smith SM
6. Gopal AK
7. Floyd JD
8. Persky DO
9. Press OW
10. Fisher RI
11. Friedberg JW
R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study.; The Lancet. Haematology; Vol 5(3). 2018 Mar.
1. Fries C
2. Burack WR
A clinical perspective on immunoglobulin heavy chain clonal heterogeneity in B cell acute lymphoblastic leukemia.; Leukemia research; Vol 75. 2018 Jan.
1. Patel N
2. Hoffman CM
3. Goldman BI
4. Bentley K
5. Burack WR
6. Evans AG
Green Inclusions in Neutrophils and Monocytes Are an Indicator of Acute Liver Injury and High Mortality.; Acta haematologica; Vol 138(2). 2017 Aug 17.
1. Burack WR
2. Spence JM
3. Spence JP
4. Spence SA
5. Rock PJ
6. Shenoy GN
7. Shultz LD
8. Bankert RB
9. Bernstein SH
Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironment.; Blood advances; Vol 1(16). 2017 Jul 11.
1. Reyes-Barron C
2. Burack WR
3. Rothberg PG
4. Ding Y
Next-Generation Sequencing for Minimal Residual Disease Surveillance in Acute Lymphoblastic Leukemia: An Update.; Critical reviews in oncogenesis; Vol 22(5-6). 2017.
1. Hunter BD
2. Herr M
3. Meacham PJ
4. Barlaskar F
5. Evans AG
6. Burack WR
7. Liesveld JL
8. Becker MW
9. Milner LA
10. Constine LS
11. Dhakal S
12. Barr PM
13. Friedberg JW
14. Casulo C
Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.; Clinical lymphoma, myeloma & leukemia. 2016 Nov 23.
1. Youn P
2. Cummings MA
3. Dhakal S
4. Burack WR
5. Casulo C
6. Barr PM
7. Friedberg JW
8. Constine LS
Prognostic Impact of Cell of Origin in Limited-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP With or Without Radiation Therapy.; International journal of radiation oncology, biology, physics; Vol 96(2S). 2016 Oct 1.
1. Redd L
2. Schmelz M
3. Burack WR
4. Cook JR
5. Day AW
6. Rimsza L
Langerhans Cell Histiocytosis Shows Distinct Cytoplasmic Expression of Major Histocompatibility Class II Antigens.; Journal of hematopathology; Vol 9(3). 2016 Sep.
1. Evans AG
2. Ahmad A
3. Burack WR
4. Iqbal MA
Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance.; Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Jul 8.